Skip to main content

Table 6 Genotypes and alleles distribution among studied groups

From: IL-28B single nucleotide polymorphism as a predictor of hepatocellular carcinoma after treatment of chronic hepatitis C patients with direct acting antivirals

Polymorphism Control group
N=100 (%)
Cirrhosis group
N=50 (%)
HCC group
N=50 (%)
Test of significance  
TT 8 (8.0) 14 (28.0) 9 (18.0) χ2=13.12 p1=0.004*
CC 28 (28.0) 10 (20.0) 7 (14.0) p=0.01* p2=0.054
CT 64 (64.0) 26 (52.0) 34 (68.0)   p3=0.26
HWE 0.008* 0.741 0.126   
Allele n=200 N=100 N=100   p1=0.02*
T 80 (40) 54 (54.0) 52 (52.0) χ2=6.87 p2=0.051
C 120 (60) 46 (46.0) 48 (48.0) p=0.03* p3=0.77
  1. *Statistically significant (if p< 0.05)